πŸ‡ΊπŸ‡Έ FDA
Patent

US 9150648

Anti-ASIC1 antibodies and uses thereof

granted A61KA61K2039/505A61K39/00

Quick answer

US patent 9150648 (Anti-ASIC1 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/505, A61K39/00, A61P, A61P25/04